Region
Featured experience
Atairos investment in the parent company of the Aston Villa Football Club
We are advising Atairos on the minority investment
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
$100 million investment by consortium in Airbus subsidiary AALTO
We are advising Airbus on the transaction
Haleon $3 billion secondary placing of ordinary shares
The private placement included 700,000,000 ordinary shares
Deutsche Bank $1 billion notes offering
The fixed-to-floating-rate eligible liabilities notes are due 2028
MSCI acquisition of Foxberry
We are advising MSCI on the acquisition
Immunocore Holdings $402.5 million convertible notes offering
The 2.5% convertible notes are due 2030
Second Circuit affirms dismissal for NatWest in Treasury market rigging case
We secured a complete victory for NatWest
Bridgepoint sale of a minority interest in Humanetics
We are advising Bridgepoint and Humanetics on the transaction
Telefónica $500 million tender offer
We advised Telefónica on its tender offer for three series of notes
Oesterreichische Kontrollbank $1.5 billion notes offering
The 4.125% notes are due 2029
National Grid $750 million notes offering
The investment-grade notes are due 2034
Roche $295 million acquisition of LumiraDx's point of care technology platform
We are advising Roche on the acquisition
Myers Industries $350 million acquisition of Signature Systems
We are advising Myers Industries on the acquisition